This trial studies how well a loupe-based fluorescein imaging device works in identifying brain malignant brain gliomas during the time of surgery. Diagnostic procedures such as loupe-based intraoperative fluorescence imaging, may help identify tumor tissues during surgery and make tumor resection easier, quicker and considerably cheaper.
Additional locations may be listed on ClinicalTrials.gov for NCT04780009.
Locations matching your search criteria
United States
Kentucky
Lexington
University of Kentucky/Markey Cancer CenterStatus: Active
Contact: Thomas A Pittman
Phone: 859-323-8986
PRIMARY OBJECTIVE:
I. To test a low-cost, miniaturized, easy-to-operate, loupe-based fluorescein or 5-ALA imaging device for the identification of malignant gliomas during the time of surgery.
OUTLINE:
Patients undergo standard of care contrast-enhanced magnetic resonance imaging (MRI) within 4 days before surgery and within 72 hours after surgery. Prior to surgery, patients receive fluorescein intravenously (IV), then undergo fluorescence imaging with the loupe-based device during surgery.
Trial PhaseNo phase specified
Trial Typediagnostic
Lead OrganizationUniversity of Kentucky/Markey Cancer Center
Principal InvestigatorThomas A Pittman
